On Monday, Angiodynamic Inc (NASDAQ: ANGO) was 5.38% up from the session before settling in for the closing price of $9.29. A 52-week range for ANGO has been $5.47 – $13.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2.66% over the last five years. When this article was written, the company’s average yearly earnings per share was at 34.05%. With a float of $38.73 million, this company’s outstanding shares have now reached $40.97 million.
The firm has a total of 748 workers. Let’s measure their productivity. In terms of profitability, gross margin is 53.45%, operating margin of -8.99%, and the pretax margin is -14.85%.
Angiodynamic Inc (ANGO) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Angiodynamic Inc stocks. The insider ownership of Angiodynamic Inc is 4.63%, while institutional ownership is 81.68%. The most recent insider transaction that took place on Jan 16 ’25, was worth 49,979. In this transaction SVP Quality and Regulatory of this company sold 4,060 shares at a rate of $12.31, taking the stock ownership to the 41,817 shares. Before that another transaction happened on Jan 16 ’25, when Company’s Officer proposed sale 4,060 for $12.31, making the entire transaction worth $49,979.
Angiodynamic Inc (ANGO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.05% per share during the next fiscal year.
Angiodynamic Inc (NASDAQ: ANGO) Trading Performance Indicators
You can see what Angiodynamic Inc (ANGO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.02, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Angiodynamic Inc (ANGO)
Analysing the last 5-days average volume posted by the [Angiodynamic Inc, ANGO], we can find that recorded value of 0.56 million was lower than the volume posted last year of 0.72 million. As of the previous 9 days, the stock’s Stochastic %D was 23.49%. Additionally, its Average True Range was 0.67.
During the past 100 days, Angiodynamic Inc’s (ANGO) raw stochastic average was set at 46.00%, which indicates a significant increase from 35.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.25% in the past 14 days, which was higher than the 80.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.86, while its 200-day Moving Average is $8.35. Now, the first resistance to watch is $9.99. This is followed by the second major resistance level at $10.19. The third major resistance level sits at $10.51. If the price goes on to break the first support level at $9.47, it is likely to go to the next support level at $9.15. Should the price break the second support level, the third support level stands at $8.95.
Angiodynamic Inc (NASDAQ: ANGO) Key Stats
There are 40,607K outstanding shares of the company, which has a market capitalization of 397.57 million. As of now, sales total 303,910 K while income totals -184,350 K. Its latest quarter income was 72,000 K while its last quarter net income were -4,410 K.
